Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
VHT vs VXF: how they differ
VHT and VXF hold 12% of their weight in the same names, and VHT returned more over the year.
Vanguard Health Care Index Fund and Vanguard Extended Market Index Fund.
What they hold in common
By the books each fund has filed, VHT and VXF hold 12% of their money in the same securities at the same weight.
| Holding | VHT | VXF |
|---|---|---|
| Alnylam Pharmaceuticals Inc | 0.63% | 0.47% |
| Natera Inc | 0.47% | 0.46% |
| REVOLUTION Medicines Inc | 0.40% | 0.44% |
| Illumina Inc | 0.39% | 0.31% |
| Insmed Inc | 0.36% | 0.27% |
| United Therapeutics Corp | 0.36% | 0.27% |
| Guardant Health Inc | 0.23% | 0.23% |
| Neurocrine Biosciences Inc | 0.25% | 0.20% |
| Tenet Healthcare Corp | 0.24% | 0.19% |
| Roivant Sciences Ltd | 0.18% | 0.19% |
| Jazz Pharmaceuticals PLC | 0.20% | 0.18% |
| Exelixis Inc | 0.20% | 0.16% |
| Only in VHT | Only in VXF |
|---|---|
| Eli Lilly & Co 14.07% | Space Exploration Technologies Corp 1.19% |
| Johnson & Johnson 8.48% | Snowflake Inc 1.03% |
| AbbVie Inc 6.10% | Bloom Energy Corp 0.93% |
| UnitedHealth Group Inc 5.46% | Cloudflare Inc 0.92% |
| Merck & Co Inc 4.67% | Astera Labs Inc 0.76% |
| Thermo Fisher Scientific Inc 2.93% | Rocket Lab Corp 0.61% |
| Amgen Inc 2.87% | Cheniere Energy Inc 0.59% |
| Gilead Sciences Inc 2.64% | Ferguson Enterprises Inc 0.54% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
| VHT Vanguard Health Care Index Fund | VXF Vanguard Extended Market Index Fund | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Vanguard | Vanguard |
| What it is | Health Care | Extended Market |
| Total return, 1 year | +21.6% | +14.1% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +4.1 pts | −3.4 pts |
| Expense ratio | 0.09% | 0.05% |
| Already in the S&P 500 | 85.6% | 0.0% |
| Holdings | 401 | 3365 |
VHT in plain words
VHT is an index equity fund tracking the Health Care. Over the year to Sep 11, 2026 it returned +21.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.09% a year. By its holdings filed for May 31, 2026, 86% of the fund by weight is stocks the S&P 500 also holds, across 401 positions, with the top ten at 52.0%. It sat 5.7% below its high of Aug 19, 2026 on Sep 11, 2026.
VXF in plain words
VXF is an index equity fund tracking the Extended Market. Over the year to Sep 11, 2026 it returned +14.1% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.05% a year. By its holdings filed for Jun 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 3365 positions, with the top ten at 7.6%. It sat 5.1% below its high of Aug 14, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, VHT or VXF?
- In the year to Sep 12, 2026, with distributions reinvested, VHT returned +21.6% and VXF returned +14.1%, so VHT returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, VHT or VXF?
- VHT charges 0.09% a year and VXF charges 0.05%, so VXF is cheaper. Fees come from each fund's prospectus.
- How much do VHT and VXF overlap with the S&P 500?
- By their latest filed holdings, 86% of VHT and 0% of VXF by weight is stocks the S&P 500 already holds. Between the two funds, 12% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, VHT against VXF, data as of Sep 12, 2026. https://etfiq.com/compare/any/VHT-VXF Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources